N@N

ICUI, LVLT, KEYN, DGX, ALKS, FNSR, Expected to Trade Lower After Bearish Insider Trading

July 8, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Lower in the next 6 months. ICU MEDICAL, INC. (NASDAQ:ICUI), LEVEL 3 COMMUNICATIONS INC (NASDAQ:LVLT), KEYNOTE SYSTEMS INCORPORATED (NASDAQ:KEYN), QUEST DIAGNOSTICS INCORPORATED (NYSE:DGX), ALKERMES, INC. (NASDAQ:ALKS), FINISAR CORPORATION (NASDAQ:FNSR) are all expected to go Lower as Sell signals have been generated by top insider trading patterns. The most important data elements considered when performing insider analysis are: Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns. Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC).

The chart below displays the stocks expected to go Lower along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score.

     Symbol     Company Name                        Insider Name                        Role        Shares         Insider Score     Avg 6 Month Return     # of Dec. 
     ICUI       ICU MEDICAL, INC.                   Saucedo, Joseph R                   D           3,000          75                -16.0%                 5         
     LVLT       LEVEL 3 COMMUNICATIONS INC          Crowe, James Quell                  CEO         195,600        100               -24.1%                 80        
     KEYN       KEYNOTE SYSTEMS INCORPORATED        Aoki, Donald J                      O           7,292          88                -7.1%                  53        
     DGX        QUEST DIAGNOSTICS INCORPORATED      Hagemann, Robert A                  CFO         4,150          98                -10.6%                 21        
     ALKS       ALKERMES, INC.                      Breyer, Robert A                    D           6,050          90                -21.9%                 43        
     FNSR       FINISAR CORPORATION                 Brown, Christopher E                GC          5,552          75                -10.4%                 9         

The insider buying report presents recent insider purchases, reported on Forms 3, 4, and 5 filed with the SEC. The transactions are aggregated to a 'decision' level which simplifies the data analysis. A decision is a grouping of buying or selling by an individual at the specified company.

ICU MEDICAL, INC. (NASDAQ:ICUI) - ICU Medical, Inc. engages in the development, manufacture, and sale of disposable medical connection systems for use in vascular therapy applications in the United States and internationally. Its disposable medical devices protect patients from catheter related bloodstream infections, and healthcare workers from exposure to diseases through accidental needle sticks or hazardous drugs. The company offers I.V. therapy lines consisting of a tube running from a bottle or plastic bag containing an I.V. solution to a catheter inserted in a patients vein for use in hospitals and ambulatory clinics; CLAVE product, a needleless I.V. connection device, which could be used with conventional peripheral or central vascular access systems for venous and arterial applications; custom infusion sets, custom oncology sets, and custom critical care sets; and CLC2000, a one piece swabbable connector used to connect I.V. lines to catheters to prevent the back-flow of blood into the catheter. It also provides critical care products that monitor vital signs and specific physiological functions of key organ systems, including pressure monitoring devices, blood sampling systems, angiography kits, sensory catheters, pulmonary artery thermodilution catheters, and multilumen central venous catheters. In addition, the company provides TEGO for use in dialysis; a line of oncology products, including Spiros male luer connector device; the Genie vial access device; the Orbit 90 diabetes set; and custom I.V. sets and ancillary products for oncology therapy. ICU Medical, Inc. sells its products through I.V. product manufacturers and independent distributors, as well as directly to the end users. The company was founded in 1984 and is headquartered in San Clemente, California.

LEVEL 3 COMMUNICATIONS INC (NASDAQ:LVLT) - Level 3 Communications, Inc. engages in the communications business in North America and Europe. It offers network and Internet services, including transport services, high speed Internet protocol services, dedicated Internet access, virtual private network services, and dark fiber services, as well as managed modem, an outsourced, turn-key infrastructure solution; and colocation services. The company also provides various media services, comprising Vyvx services that provide audio and video feeds over fiber or satellite; content delivery network services; media delivery services to customers seeking to manage, protect, and monetize content delivered over the Internet; a range of local and long distance voice services, such as voice over Internet protocol (VoIP) and traditional circuit-switch based services; and VoIP Enhanced Local, a VoIP service that enables broadband cable operators, IXCs, VoIP providers, and other companies operating their own switching infrastructure to launch IP-based local and long-distance voice services through a broadband connection. Level 3 Communications media services also consist of SIP Trunking, a VoIP-based local phone service; Local Inbound service that terminates traditional telephone network originated calls to Internet Protocol termination points; Primary Rate Interface, a TDM local phone service that could be configured in various ways; Long Distance services portfolio comprising local and long distance transport and termination services; and Toll Free services portfolio, which terminate toll free calls that are originated on the traditional telephone network. As of December 31, 2009, its network encompassed approximately 67,000 intercity route miles in North America and an intercity network covering approximately 12,000 miles across Europe. Further, it sells coal primarily through long-term contracts with public utilities. The company was founded in 1884 and is headquartered in Broomfield, Colorado.

KEYNOTE SYSTEMS INCORPORATED (NASDAQ:KEYN) - Keynote Systems, Inc. provides Internet and mobile cloud monitoring solutions worldwide. The company offers Internet cloud products and services, including Transaction Perspective to provide visibility into the performance and availability of Web transactions from the end-user perspective; Application Perspective, a Web application monitoring service; Streaming Perspective to measure, compare, and assure the performance of audio and video streams; and Private Agents for the performance of mission critical extranet and intranet applications. Its Internet cloud products and services also comprise Performance Scoreboard, a customizable dashboard; Enterprise Adapters that integrates its performance measurement data into enterprise systems management platforms; Red Alert to test devices connected to the Internet; LoadPro, a Web load testing service; Test Perspective, a self-service load testing service; Keynote Internet Testing Environment, a desktop tool for real-time testing, diagnosing, and troubleshooting of Web performance issues; and consulting services, such as performance insights, web site performance assessment, automated reporting, and custom competitive research. In addition, the company provides mobile cloud products and services consisting of System Integrated Test Environment System to test and measure the quality and reliability of mobile networks, mobile applications, and content delivery for mobile operators; GlobalRoamer to certify and validate roaming agreements across multiple mobile operators; Mobile Device Perspective to improve the quality of mobile contents, applications, and services; Mobile Web Perspective for monitoring and troubleshooting quality and performance issues for mobile Web sites; and Mobile Internet Testing Environment, a desktop tool. Further, it offers professional services, mobile competitive monitoring and analysis, and mobile insights. The company was founded in 1995 and is headquartered in San Mateo, California.

QUEST DIAGNOSTICS INCORPORATED (NYSE:DGX) - Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. It offers patients and physicians the access to diagnostic testing services through its network of laboratories and patient service centers; and interpretive consultation services. The company provides commercial clinical testing services, including routine clinical testing for blood chemistries, complete blood cell counts, urinalyses, pregnancy and other prenatal tests, routine microbiology testing, prescription drug monitoring, alcohol and other substance-abuse tests, and allergy tests; gene-based and esoteric testing; and anatomic pathology services, as well as risk assessment services for the life insurance industry. It also develops and integrates clinical connectivity and data management solutions for healthcare organizations, physicians, and clinicians through its Care360 suite of products; and offers Centergy Data Exchange and the ChartMaxx electronic document management system to hospitals. In addition, the company provides central laboratory testing services in connection with clinical research trials on new drugs, vaccines, and medical devices; and clinical testing to employers for the detection of employee use of drugs-of-abuse. Further, it develops and manufactures products that enable healthcare professionals to make healthcare diagnoses, including HerpeSelect ELISA tests that detect patient antibodies to certain types of herpes simplex virus, and sells to academic medical centers, hospitals, and commercial laboratories; White Blood Cell Analyzer for performing whole-blood test on finger-stick samples; and InSure fecal immunochemical test for screening for colorectal cancer. The company was founded in 1967 and is headquartered in Madison, New Jersey.

ALKERMES, INC. (NASDAQ:ALKS) - Alkermes, Inc., an integrated biotechnology company, provides extended-release injectable and oral products for the treatment of prevalent and chronic diseases, such as central nervous system disorders, reward disorders, addiction, diabetes, and autoimmune disorders. The company develops, manufactures, and commercializes VIVITROL, an injectable medication for the treatment of alcohol dependence; and manufactures RISPERDAL CONSTA for the treatment of schizophrenia and bipolar I disorders. It is also developing BYDUREON, a once weekly formulation of exenatide for the treatment of type 2 diabetes; ALKS 33, an oral opioid modulator for the potential treatment of addiction and other CNS disorders; ALKS 37, an orally active, peripherally-restricted opioid antagonist for the treatment of opioid-induced constipation; ALKS 9070, a once-monthly, injectable, sustained-release version of aripiprazole for the treatment of schizophrenia; ALKS 6931, a long-acting form of a TNF receptor-FC fusion protein for the treatment of rheumatoid arthritis and related autoimmune diseases; and ALKS 7921, a once-monthly, injectable, and extended-release version of olanzapine for the treatment of schizophrenia. The company has collaborative arrangements with Janssen Pharmaceutica, Inc.; Amylin Pharmaceuticals, Inc.; Cilag GmbH International; Rensselaer Polytechnic Institute; and Acceleron Pharma, Inc. Alkermes, Inc. was founded in 1987 and is headquartered in Waltham, Massachusetts.

FINISAR CORPORATION (NASDAQ:FNSR) - Finisar Corporation designs, develops, manufactures, and markets optical subsystems and components that are used to interconnect equipment in short-distance local area networks (LANs), storage area networks (SANs), longer distance metropolitan area networks (MANs), fiber-to-the-home networks, cable television networks, and wide area networks. Its optical subsystems primarily include transmitters, receivers, transceivers, and transponders. The companys optical subsystems provides the fundamental optical-electrical interface for connecting the equipment used in building networks comprising switches, routers, and file servers in wireline networks, as well as antennas and base stations for wireless networks. It also offers products for switching network traffic from one optical wavelength to another across multiple wavelengths, known as reconfigurable optical add/drop multiplexers. The companys line of optical components principally comprises packaged lasers and photodetectors used in transceivers for LAN and SAN applications; and passive optical components used in building MANs. It sells its optical products to manufacturers of storage system, networking equipment, and telecommunication equipment or their contract manufacturers through direct sales force and distribution channels in the United States, Malaysia, the Peoples Republic of China, and internationally. The company was founded in 1987 and is headquartered in Sunnyvale, California.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

Insider Trading tracks all insider trades and selects those insider buys that predict higher moves and insider sales that predict lower moves.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net